Portola Pharmaceuticals' Series D - II Round

Portola Pharmaceuticals raised a round of funding on December 21, 2011.

Portola is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who curren…

Articles about Portola Pharmaceuticals' Series D - II Round: